Summary Report on Adverse Events Following Immunisation of COVID-19 Vaccines in Malaysia

This report provides summarised updates on adverse events following immunisation (AEFIs) of COVID-19 Vaccines in Malaysia.

To receive the latest issues of summary report, you may join the NPRA Safety Information Mailing List by filling out the subscription form at https://forms.gle/x7eim2Z99HKVNSsz6.

Summary Report on Adverse Events Following Immunisation of COVID-19 Vaccines in Malaysia (Data as of 10th June 2022)

Introduction

  • How does NPRA collect adverse event reports?
  • How does NPRA process AEFI reports and monitor safety of COVID-19 vaccines?

Total Doses of COVID-19 Vaccines Administered

Rate of Reported Adverse Events

  • AEFI responses received via MySejahtera application
  • AEFI reports received via NPRA Reporting System
  • Booster doses (PICK-B)
  • COVID-19 vaccination in adolescents aged 12 to 17 years
  • COVID-19 vaccination in children aged 5 to 11 years

Adverse Events of Special Interest

 

Summary

  • Protective benefits of COVID-19 vaccination outweigh the potential risks
Image

Summary Report on Adverse Events Following Immunisation of COVID-19 Vaccines in Malaysia (Data as of 11th March 2022)

Introduction

  • How NPRA collects adverse event reports?
  • How NPRA processes AEFI reports and monitors safety of COVID-19 vaccines?

Total Doses of COVID-19 Vaccines Administered

Rate of Reported Adverse Events

  • AEFI responses received via MySejahtera application
  • AEFI reports received via NPRA Reporting System
  • Booster doses (PICK-B)
  • COVID-19 vaccination in children aged 5 to 11 years (PICKids)

Adverse Events of Special Interest

 

Summary

  • Protective benefits of COVID-19 vaccination outweigh the potential risks
Image

Summary Report on Adverse Events Following Immunisation of COVID-19 Vaccines in Malaysia (Data as of 31st December 2021)

Introduction

  • How NPRA collects adverse event reports?
  • How NPRA processes AEFI reports and monitors safety of COVID-19 vaccines?

Total Doses of COVID-19 Vaccines Administered

Rate of Reported Adverse Events

  • AEFI responses received via MySejahtera application
  • AEFI reports received via NPRA Reporting System
  • COVID-19 vaccination in the age of 12 to 17 years
  • Booster doses

Adverse Events of Special Interest
 

Summary

  • Protective benefits of COVID-19 vaccination outweigh the potential risks
Image

Summary Report on Adverse Events Following Immunisation of COVID-19 Vaccines in Malaysia (Data as of 29th October 2021)

Introduction

  • How NPRA collects adverse event reports?
  • How NPRA processes AEFI reports and monitors safety of COVID-19 vaccines?

Total Doses of COVID-19 Vaccines Administered

Rate of Reported Adverse Events

  • AEFI responses received via MySejahtera application
  • AEFI reports received via NPRA Reporting System

 

Summary

  • Protective benefits of COVID-19 vaccination outweigh the potential risks
Image

National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti (Jalan Profesor Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.
  • Email: npra@npra.gov.my
  • Phone: +603-7883 5400
  • Fax: +603-7956 2924, +603-7956 7075

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Site Last Modified

  • Last Modified: Rabu 17 Ogos 2022, 09:53:12.
© Copyright 2022 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA

Search

Choose Your Language